These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31322822)

  • 1. Emerging roles of exosomal miRNAs in breast cancer drug resistance.
    Najminejad H; Kalantar SM; Abdollahpour-Alitappeh M; Karimi MH; Seifalian AM; Gholipourmalekabadi M; Sheikhha MH
    IUBMB Life; 2019 Nov; 71(11):1672-1684. PubMed ID: 31322822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal microRNA: a novel biomarker for breast cancer.
    He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
    Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes.
    Zhong S; Chen X; Wang D; Zhang X; Shen H; Yang S; Lv M; Tang J; Zhao J
    Oncotarget; 2016 Apr; 7(15):19601-9. PubMed ID: 26910922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells.
    Chen WX; Xu LY; Qian Q; He X; Peng WT; Zhu YL; Cheng L
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30201690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of exosomal microRNAs in lung cancer biology and clinical applications.
    Hu C; Meiners S; Lukas C; Stathopoulos GT; Chen J
    Cell Prolif; 2020 Jun; 53(6):e12828. PubMed ID: 32391938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
    Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review).
    Li H; Li X; Du W
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of exosomal miRNAs in multi-drug resistance in cancer chemotherapeutics.
    Mowla M; Hashemi A
    Exp Mol Pathol; 2021 Feb; 118():104592. PubMed ID: 33296693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.
    Mao L; Li J; Chen WX; Cai YQ; Yu DD; Zhong SL; Zhao JH; Zhou JW; Tang JH
    Tumour Biol; 2016 Apr; 37(4):5247-56. PubMed ID: 26555545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H
    Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes and exosomal RNAs in breast cancer: A status update.
    Lakshmi S; Hughes TA; Priya S
    Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1.
    Zhao Y; Jin LJ; Zhang XY
    Aging (Albany NY); 2021 Jul; 13(14):18498-18514. PubMed ID: 34292880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance.
    Zhao L; Liu W; Xiao J; Cao B
    Cancer Lett; 2015 Jan; 356(2 Pt B):339-46. PubMed ID: 25449429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal cancer drug resistance: the role of exosomal miRNAs.
    Salehi M; Vafadar A; Khatami SH; Taheri-Anganeh M; Vakili O; Savardashtaki A; Negahdari B; Naeli P; Behrouj H; Ghasemi H; Movahedpour A
    Mol Biol Rep; 2022 Mar; 49(3):2421-2432. PubMed ID: 34850336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of exosomes and miRNAs in drug-resistance of cancer cells.
    Bach DH; Hong JY; Park HJ; Lee SK
    Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.